IM Cannabis Corp. (IMCC)
NCM · Healthcare · Drug Manufacturers - Specialty & Generic
$0.23
-6.07%
Closing price as of 2026-06-12 · Source: TEK2day Finance
Key Metrics
Market Cap
$2.1M
Shares Outstanding
9.0M
P/S (TTM)
0.0x
Exchange
NCM
Currency
USD
About IM Cannabis Corp.
IM Cannabis Corp. engages in importation, distribution and sale of medical cannabis products in Israel and Germany. It provides medical cannabis dried flowers; and full-spectrum cannabis extracts under the IMC, BLKMT, and LOT420 brands. The company serves medical patients. IM Cannabis Corp. was founded in 2008 and is headquartered in Vancouver, Canada.
Quarterly Financials
| Metric | 2024-12-31 | 2025-03-31 | 2025-06-30 | 2026-03-31 |
|---|---|---|---|---|
| Revenue | 13.3M | 12.5M | 12.7M | 8.7M |
| Gross Profit | 2.7M | 3.4M | 3.4M | 1.4M |
| Operating Income | -3.5M | 158K | -350K | -1.7M |
| Net Income | -1.0M | 275K | -309K | -2.3M |
| Diluted EPS | $nan | $0.09 | $-0.09 | $-0.38 |
Annual Financials
| Metric | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | 54.3M | 48.8M | 54.0M | 54.7M |
| Gross Profit | 9.2M | 9.8M | 8.5M | 9.7M |
| Operating Income | -22.5M | -12.2M | -10.2M | -11.6M |
| Net Income | -188.9M | -9.5M | -10.6M | -11.3M |
| Diluted EPS | $-161.88 | $-4.45 | $-4.51 | $-2.67 |